Mersana Therapeutics | ARS: Annual Report to Security Holders
Mersana Therapeutics | DEF 14A: Definitive information statements
Mersana Therapeutics | DEFA14A: Others
Mersana Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alleva Lawrence M
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 424B5: Prospectus
Mersana Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mersana Therapeutics | 10-K: Annual report
Mersana Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Mersana Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Mandelia Ashish
Mersana Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(9.4%),VHCP Co-Investment Holdings III, LLC(9.4%), etc.
Mersana Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-SilverArc Capital Management, LLC(5.3%),Devesh Gandhi(5.3%)
Mersana Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Capital LLC(0.0%),OrbiMed Advisors LLC(0.0%)
Mersana Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
Mersana Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Balyasny Asset Management L.P.(8.04%),BAM GP LLC(8.04%), etc.
Mersana Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.17%)
Mersana Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.5%)
Mersana Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.93%)
Mersana Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Protopapas Anna
No Data